Introduction Management options for women with placenta accreta spectrum (PAS) comprise termination of pregnancy before the viable gestational age, leaving the placenta in situ for subsequent reabsorption of the placenta or delayed hysterectomy, manual removal of placenta after vaginal delivery or during cesarean section, focal resection of the affected uterine wall, and peripartum hysterectomy. The aim of this observational study was to describe actual clinical management and outcomes in PAS in a large international cohort. Material and methods Data from women in 15 referral centers of the International Society of PAS (IS-PAS) were analyzed and correlated with the clinical classification of the IS-PAS: From Grade 1 (no PAS) to Grade 6 (inv...
Introduction: Incidence of placenta previa is 3-5per 1000 pregnancies. Placenta previa includes: i) ...
International audienceObjective To describe and compare the characteristics of women with placenta a...
Placenta accreta is a severe pregnancy complication and is currently the most common indication for ...
Introduction Management options for women with placenta accreta spectrum (PAS) comprise termination ...
INTRODUCTION: Management options for women with placenta accreta spectrum (PAS) comprise termination...
The increasing incidence of caesarean delivery (CD) has resulted in an increase in placenta accreta ...
Objective:Cesarean hysterectomy is generally presumed to decrease maternal morbidity and mortali...
peer reviewedOBJECTIVES: Maternal mortality related to the placenta accreta spectrum (PAS) disorders...
The worldwide incidence of placenta accreta spectrum (PAS) is rapidly increasing, following the tren...
Placenta accreta spectrum (PAS) disorder is a potentially life-threatening complication. The inciden...
Abstract Background The unique clinical features of pregnancy termination in the second trimester wi...
Abstract Background We aimed to investigate the risk factors of placenta accreta spectrum (PAS) diso...
Placenta accreta spectrum (PAS) disorders have been on the rise in recent years with increasing caes...
Placenta accreta spectrum (PAS) disorders is a multifactorial process that encompasses a heterogeneo...
The worldwide incidence of placenta accreta spectrum (PAS) is rapidly increasing, following the tren...
Introduction: Incidence of placenta previa is 3-5per 1000 pregnancies. Placenta previa includes: i) ...
International audienceObjective To describe and compare the characteristics of women with placenta a...
Placenta accreta is a severe pregnancy complication and is currently the most common indication for ...
Introduction Management options for women with placenta accreta spectrum (PAS) comprise termination ...
INTRODUCTION: Management options for women with placenta accreta spectrum (PAS) comprise termination...
The increasing incidence of caesarean delivery (CD) has resulted in an increase in placenta accreta ...
Objective:Cesarean hysterectomy is generally presumed to decrease maternal morbidity and mortali...
peer reviewedOBJECTIVES: Maternal mortality related to the placenta accreta spectrum (PAS) disorders...
The worldwide incidence of placenta accreta spectrum (PAS) is rapidly increasing, following the tren...
Placenta accreta spectrum (PAS) disorder is a potentially life-threatening complication. The inciden...
Abstract Background The unique clinical features of pregnancy termination in the second trimester wi...
Abstract Background We aimed to investigate the risk factors of placenta accreta spectrum (PAS) diso...
Placenta accreta spectrum (PAS) disorders have been on the rise in recent years with increasing caes...
Placenta accreta spectrum (PAS) disorders is a multifactorial process that encompasses a heterogeneo...
The worldwide incidence of placenta accreta spectrum (PAS) is rapidly increasing, following the tren...
Introduction: Incidence of placenta previa is 3-5per 1000 pregnancies. Placenta previa includes: i) ...
International audienceObjective To describe and compare the characteristics of women with placenta a...
Placenta accreta is a severe pregnancy complication and is currently the most common indication for ...